Preparing COVID-19 Vaccine Moderna at PCN Designated Sites

Sue Dickinson, Director of Pharmacy, Regional Drug & Therapeutics Centre (Newcastle)Published Last updated See all updates

Standard Operating Procedure for preparation of the Moderna Spikevax® COVID-19 Vaccine in PCN designated sites prior to immediate administration.

Information

A standard operating procedure is attached to this page.

Within the SOP:

  • GREEN TEXT indicates that detail is awaited and will be added when available
  • RED TEXT indicates where detail is to be added locally

You should also familiarise yourself with our background guide Facilitating Pharmaceutical support to PCN Designated Sites for COVID-19 vaccinations before using this SOP

These documents may be adapted by Superintendent Pharmacists for the use of the vaccine in community pharmacy settings

Attachments

Other handling content for PCNs

Other COVID-19 vaccines resources

What to do if you still have questions

If you still have questions you can get in touch with us. However, please first read our service remit; and if you still think we can help, use the email address below.

We're supporting healthcare professionals in England with pharmaceutical aspects of the COVID-19 vaccination programme; read our service remit to find out more.
If you're a healthcare professional in England, get in touch with us if you still have questions

Change history

  1. MVH3 Section 5.2.3 Amended reference to storage up to 25 degrees C to reflect extended time of 24 hours
  2. MVH3 Section 5.4.2 removal of outdated Foundry codes
  3. MVH 3 3.1 and 3,2 the name of the vaccine has changed to Spikevax®
  1. MVH3 Section 5.3.1 amended to allow 11 doses to be withdrawn from each vial
  2. MVH3.1 renumbered
  1. Published